Introduction
The vascular endothelium plays a leading role in maintaining vascular homeostasis by controlling various processes in the vascular wall, on the endothelial-cell surface and in the blood stream.
Although the differential phenotype of endothelial cells at different positions of the vascular tree has become an intruiging field of study over the past decades, all endothelial cells are derived from the same origin. 1 During embryogenesis, in a process known as vasculogenesis, the vascular tract develops from the vascular plexus, which in turn is derived from the blood islands that constitute both endothelium forming and blood forming cells. Blood islands develop from the hemangioblast, the common precursor for the endothelial cell and the hematopoietic cell. 2 Throughout the further development and maturation of the vascular network, the endothelial forming cells differentiate into a fully functional endothelial cell and finally acquire their endothelial-specific properties that are involved in the regulation of haemostasis, endothelial barrier function, inflammatory response, vasomotor function, leukocyte extravasation and angiogenesis. 3 Therefore, in contrast to the lineagespecific gene expression that uniquely defines the endothelial precursor during the various stages of vasculogenesis, the expression of a discrete group of mostly endothelial-specific genes is vital to the functionally differentiated mature endothelium. It has been postulated that shear stress, the tangential force exerted by the flowing blood on the vascular endothelial lining is of prime importance in determining endothelial phenotype. 4, 5 Over recent years, the zinc finger transcription factor lung Krüppel-like factor (LKLF/KLF2) has emerged as a prime and pivotal candidate for directly relaying biomechanical shear forces into a gene transcription profile that might determine endothelial phenotype in response to flow. [6] [7] [8] [9] [10] We previously demonstrated that KLF2 mRNA and protein levels are substantially and uniquely induced by prolonged steady or pulsatile laminar flow both in vitro and in vivo. 6, 10 Furthermore, we have demonstrated that KLF2 is specifically expressed in endothelial cells of the adult vasculature but its only.
For personal use at PENN STATE UNIVERSITY on . bloodjournal.hematologylibrary.org From expression drops to low levels near sites of flow disturbance, coinciding with regions that show pathological changes of the vascular wall. 10 The remarkably stable transcriptional induction of KLF2 specifically by flow therefore suggests a role for KLF2 as an intermediary transcriptional regulator of endothelial flow-specific gene expression. Indeed, we showed KLF2 to be essential in the shearinduced upregulation of endothelial nitric oxyde synthase (eNOS), one of the prime flow-responsive endothelial genes, by combined siRNA and flow experiments. 9 In addition, KLF2 has recently been identified as a pivotal transcription factor in regulating endothelial vasomotor function, inflammatory response, haemostasis, and angiogenesis. [7] [8] [9] [10] Still, despite this seemingly central role in various aspects of endothelial physiology, early studies using knock-out mice have demonstrated that absence of KLF2 does not impede primary vasculogenesis. 11 Rather, the embryonic lethal phenotype is caused by the fact that KLF2 is essential for the stabilization of the immature vascular tract by recruited smooth muscle cells. Given the tentative pivotal role of flow on endothelial physiology, a dissection of KLF2-induced gene expression profiles from general flow-induced processes would be a first step in identifying the specific role of KLF2 in the endothelial gene expression repertoire and differentiation.
We investigated the steady-state changes in endothelial gene expression that are caused by a prolonged and stable overexpression of KLF2. By using genome-wide microarray-based gene expression analysis we established the full repertoire of both directly and indirectly KLF2-regulated endothelial cell gene expression. The primary bioinformatics analysis is complemented by real-time 
Materials and methods

Cell culturing and Lenti-viral KLF2 overexpression
Human umbilical vein endothelial cell (HUVEC) isolation, culturing and Lenti-viral overexpression of KLF2 was previously described. 6, 10, 12 rhVEGF 165 and rhTNFα (R&D Systems, Minneapolis, MN)
were used at concentrations of 40 and 10 ng/ml, respectively.
RNA isolation, microarray expression profiling and pathway analysis
Total RNA was isolated using the Trizol reagent (Invitrogen, Carlsbad, CA) and enriched for poly- 
Semi-quantitative real-time RT-PCR
Real-time RT-PCR was performed on total RNA isolated using the Absolutely RNA RT-PCR Miniprep Kit (Stratagene, La Jolla, CA) as described. 10 All primers were designed using Primer3
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). 15 After correction for the housekeeping controls hypoxanthine phosphoribosyltransferase 1 and large ribosomal phosphoprotein P0, the mRNA levels were expressed as ratios compared to the mock-transduced control cultures.
Western blotting and immunofluorescence
Western blotting and immunofluoresence were performed as described. 10, 16 Vascular endothelial growth factor receptor-2 (VEGFR2/KDR), phospho-VEGFR2, thrombomodulin (TM), plasminogen activator inhibitor type 1 (PAI-1), eNOS and RalA antibodies were from R&D Systems, Abcam (Cambridge, UK), DakoCytomation (Glostrup, Denmark), Biopool (Umea, Sweden) and BD Transduction Laboratories (San Diego, CA), respectively. Specific peptide anti-sera against human KLF2 were previously described. 10 For immunofluorescence, KLF2-and mock-transfected HUVEC were grown on gelatin-coated glass coverslips and fixed with paraformaldehyde. Secondary antibodies were TRITC-labeled and phalloidin-FITC/TRITC was used as a stain for F-actin.
vWF was detected using a polyclonal anti-vWF antibody (DakoCytomation) and a TexasRed-labeled secondary goat anti-rabbit antibody. Cells were embedded and viewed by confocal microscopy using a Zeiss LSM510. Images were generated by making optical sections (Z-stacks with 400 nm intervals) and three-dimensional analysis using depth-coding software (application for Zeiss only.
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Protein C activation assay
Assays were performed as described. 18 Confluent monolayers of HUVEC were washed three times and assay buffer containing 12 nM thrombin and 5 ng/ml protein C was added. After 20 min, an aliquot was removed and protein C activation was quenched by adding hirudin (Sigma) to 40 nM.
The chromogenic substrate S-2366 was added and the rate of change in optical absorbance at 405 nm was monitored with the EL808 Microplate Reader (Bio-TEK, Winooski, VT).
Migration assay
Wounding assays were performed as described. 19 Briefly, confluent HUVEC monolayers, which had been transduced with Lentivirus expressing the KLF2 gene (Lenti-KLF2) 10 or amock Lentivirus (Lenti-mock), were grown on fibronectin. Cells were removed by scraping across the surface of a 6-well culture plate using a modified plastic cell scraper. Standard phase-contrast microphotographs were analyzed in Adobe Photoshop 5.0 (Adobe Systems, San Jose, CA). The numbers of pixels that the wounds had decreased in width after 24, 48 or 72 hours were converted to distance (μm) by calibrating the setup with a Buerker cell counting chamber.
Assaying von Willebrand factor release
The thrombin or forskolin-induced secretion of vWF from KLF2-transduced or mock-transduced HUVEC was assessed by quantification of secreted vWF antigen and by counting the decrease in the number of WPBs in fixed cells, essentially as described. 20 In brief, endothelial cells grown for 24 hours in 6-well plates were washed two times with serum-free medium (SFM), containing 1%
only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From human albumin. Subsequently, the cells were pre-incubated with SFM for 1 hour, which was substituted with SFM containing thrombin, forskolin or epinephrin and 100 μM isobutylmethylxanthine (IBMX) (Sigma-Aldrich Chemie, Steinheim, Germany), or no stimulating agent.
Statistical analysis
Expression data are given as mean±SEM for the indicated number of experiments. The unpaired Student's t test was used to calculate the statistical significance of the expression ratios versus control cultures. P values less than 0.05 were considered statistically significant. 
Results
Identification of the KLF2 transcriptional targets
We previously described a Lentivirus-driven overexpression approach, where human KLF2 is expressed using the relatively moderate phosphoglycerate kinase (PGK) promotor, thereby increasing KLF2 expression to levels similar to those observed in HUVEC that are exposed to prolonged pulsatile flow. 10 Following transduction of five independent HUVEC cultures with the derived from the mock and KLF2 transductions, were hybridized to the arrays with replicate dyeswap hybridizations. Thus, a total of ten experimental and technical replicate expression data sets, comparing mock and KLF2 transductions, were obtained and significant differential gene expression was statistically evaluated using the Rossetta Resolver ® Gene Expression Data Analysis System. Figure 1A shows the composite MA plot of the complete 10-array dataset. After data filtering, i.e. absolute ratio>1.5, 10-base log of average intensity>1.3 and FDR-corrected P-value<0.001, a total of 1039 (600 induced, 439 repressed) genes remained that were statistically significant differentially expressed (see online data supplement). Real-time RT-PCR was used to verify the KLF2-mediated transcriptional regulation of a selection of genes (Fig. 1B) . The results show that all 24/24 genes tested were regulated to similar or higher extents when probed by independent RT-PCR analysis.
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Lineage-specific endothelial gene expression is not controlled by KLF2
The genomic profiling indicates a pleiotropic effect of KLF2 on endothelial gene expression, raising the possibility that KLF2 is involved in determining endothelial lineage. The endothelium expresses a number of lineage markers genes that are already expressed during the early stages of vascular patterning and primary vascular development. 1, 2, 21, 22 The gene expression data presented here demonstrate that prolonged KLF2 overexpression only marginally affects the expression of these marker genes that are important during early vasculogenesis (Table 1 
KLF2 controls endothelial functional differentiation
The large number of KLF2 downstream genes that were identified, necessitates sorting them into distinct processes that are of particular interest to endothelial cell biology. Therefore, a combination of Gene Ontology ordering, GenMAPP pathway analysis and Ingenuity PubMed text-mining was performed to provide a global functional view on the KLF2 effect. This approach ranks genes into the different processes in which they are involved, consistent with the complex matrix of genes and functions in biology. Thus, a number of categories were identified showing a high level of regulation by KLF2. Remarkably, they describe typical vascular biological processes in which the fully only.
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KLF2 alters endothelial morphology and migration
As many genes and processes are affected by sustained KLF2 expression, we first investigated its effect on classical cultured HUVEC phenotype. First, correct targeting of the KLF2 protein to the endothelial nucleus was evidenced by using specific peptide antisera 10 in immunofluorescence ( Fig.   2A,B) . Phase-contrast microscopy showed a stretched appearance of HUVEC overexpressing KLF2 for 5 days, compared to the typical cobble stone shape of the confluent mock-transduced cultures (Fig. 2C,D) . Lenti-KLF2 cultures that were allowed to grow to complete confluence had a cell density of 596±10 cells/mm 2 , compared to 382±13 cells/mm 2 for Lenti-mock cultures. Staining for F-actin using fluorescently-labeled phalloidin revealed a major reorganization of the cytoskeleton after prolonged KLF2 overexpression, characterized by the formation of typical stress fibers ( Fig.   2E-H) . As a substantial number of KLF2 sensitive genes have been implicated in cell motility by pathway analysis (Table 2) , endothelial cell migration was studied using a standard wounding assay of HUVEC growing on a fibronectin matrix. Untransduced and mock-virus transduced HUVEC cultures both exhibited a constant migration rate of approximately 10 µm/h ( Fig. 3A and B) , closing the 1.5 mm wound within 72 hours. In marked contrast, wounded KLF2-overexpressing monolayers exhibited a greatly reduced migration rate of 2.8 µm/h and failed to close within 72 hours. As cell only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From motility is an important aspect of angiogenesis, we next investigated the potential involvement of the decreased angiogenic response caused by the downregulation of VEGFR2 that was observed at the mRNA level (Fig. 1B and Table 1 ). In agreement with the decrease in gene expression, the total VEGFR2 protein levels are shown to be decreased by KLF2 overexpression, and were not significantly affected by stimulation with VEGF for up to 24 hours (Fig. 3C) . Unexpectedly, KLF2 overexpression did not have a large effect on the VEGF-induced phosphorylation of the VEGFR2 protein at residues Y951 and Y1059, which is essential for VEGF-induced proliferation and migration, respectively (Fig. 3C) . Thus, the observed KLF2-induced decrease in total VEGFR2 protein only marginally affects its VEGF-mediated phosphorylation that is responsible for cell migration. The robust 16-fold induction of semaphorin-3F (SEMA3F) by KLF2 (Fig.1B ) can be essential with respect to cell migration, 23 but further functional studies are presently precluded by a lack of specific antibodies.
KLF2 controls stable expression of endothelial marker genes
Among the genes shown to be regulated by KLF2 (Table 2 ) are several of the best known endothelial signature genes, including TM (THBD), eNOS (NOS3) and vWF (VWF). Immunofluorescence confocal imaging analysis showed sustained expression of the endothelial marker protein vWF, whereas both TM and eNOS were expressed at highly increased levels (Fig. 4) . It is quite noteworthy that both TM and eNOS are specifically expressed at the plasma membrane in KLF2-expressing cells. The magnitude of the KLF2-mediated transcriptional regulation of TM and eNOS was confirmed at the protein level on KLF2 Lenti-virus transduced HUVEC cultures (Fig. 5A) .
Expression of these genes, which are also involved in haemostasis, is generally restricted to the differentiated endothelial cell and sensitive to stimuli such as inflammatory cytokines and growth factors. 24, 25 In contrast, KLF2-suppressed PAI-1 (SERPINE1) is only produced by activated or only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From inflamed endothelium. 26 As we previously showed that endogenous KLF2 expression is highly sensitive to inflammatory cytokines like TNF-α, 6 we analyzed its effect under the sustained overexpression of KLF2. Protein levels of the uncomplexed form of PAI-1 were low in lysates of both mock and KLF2-overexpressing cells (Fig. 5A ). However, a prominent band at ~60 kD was induced by TNF-α but absent after prolonged KLF2 overexpression. The reactivity of this band with the PAI-1 antibody suggests that the majority of PAI-1 is complexed to urokinase-type plasminogen activator as based on the molecular mass of the band. 27 Interestingly, we found that sustained exogenous KLF2 expression leads to induced levels of TM and eNOS even after a 6-h treatment with TNF-α, at only slightly lower levels than in the absence of TNF-α (Fig. 5A ). Functional analysis of protein C activation indeed showed that KLF2 is able to largely prevent the down-regulation of TM-dependent protein C activation normally caused by TNF-α (Fig. 5B) . These results reveal that the modulation of TM, eNOS and PAI-1 expression by inflammatory cytokines alone is vastly compensated by the prolonged overexpression of KLF2.
KLF2 controls consistent von Willebrand factor expression without interfering with its regulated release
Immunohistochemical staining for the presence of WPBs, the endothelial-specific vWF storage organelles, is most often used to establish a specific and quiescent endothelial phenotype. We noted a 2-fold induction of the vWF mRNA by KLF2 in array and real-time RT-PCR analysis and immunofluorescence confocal imaging suggested an increased expression of vWF in our cultures at the protein level (Fig. 4E,F) . In addition, it is quite noteworthy that WPB-stored vWF, which is normally heterogeneously expressed in cell culture is now homogeneously distributed in the endothelial-cell population after prolonged KLF2 expression, reminiscent of its consistent in vivo endothelial expression. 6, 10, 40 In agreement with this macroscopic analysis, the quantification of the only.
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distribution of the WPB number per cell over the entire population, rather than enhancing the maximal number of WPBs per individual cell (Fig. 6A) . A direct involvement of the basal KLF2 levels of static cells in regulating the vWF expression levels is unlikely given the lack of effect of our previously reported KLF2 siRNA 10 on the number and the heterogeneous distribution pattern of WPBs (data not shown). Interestingly, we did notice a slight decrease in the basal secretion level of vWF in Lenti-KLF2 cells, indicating a more efficient storage in WPBs (Fig. 6B) .
In order to systematically study any potential changes in vWF storage and release in/from the WPBs, various aspects of induced vWF secretion were studied next. First, the amount of vWF released in the culture medium after treatment with thrombin or forskolin, both potent inducers of vWF release from these organelles, was determined (Fig. 6B ). In agreement with the KLF2-induced increase in vWF mRNA and protein storage , the maximal amount of vWF protein that can be released from these cultures is almost 2-fold increased by KLF2. Second, the mechanism of stimulated WPB exocytosis involves activation of the small GTP-binding protein RalA (v-ral simian leukemia viral oncogene homolog A). 20 The microarray analysis presented here shows a 3.1-fold (P=10 -35 ) repression of the RalA mRNA after prolonged KLF2 overexpression (Table 2) , which is confirmed by Western blotting showing a 7-fold reduction of RalA protein levels (Fig. 6C) . However, colocalization of RalA with vWF in a subset of WPBs is still observed in dual immunofluorescence irrespective of the lower RalA levels in KLF2-overexpressing cells (Fig. 6D) . These findings raise the question whether the acute vWF secretion by the endothelium is significantly affected by KLF2.
Time course experiments did not reveal differences in the stimulated WPB release kinetics (Fig. 6E) ,
and an equal decrease in the number of WPBs after thrombin or forskolin treatment was observed (Fig. 6F) . These findings led us to conclude that, despite the decreased RalA levels, the mechanism of vWF secretion from the WPBs is basically unaffected by KLF2, in agreement with the consistent only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From colocalization of RalA with WPBs in KLF2-overexpressing cells. Finally, the sensitivity of the stimulated vWF release response after treatment with increasing doses of the physiologically relevant agents thrombin and epinephrine, was assessed. No significant difference between the dose response of epinephrine-induced vWF secretion was observed (Fig. 6G) . In marked contrast, thrombin failed to induce vWF secretion at concentrations below 0.1 U/ml (Fig. 6H) , showing a KLF2-mediated desensitized thrombin response. In conclusion, increased stimulated vWF secretion was observed in KLF2-overexpressing cells as a result of a more efficient vWF storage and WPB distribution over the cell population, rather than that the basic mechanism of vWF secretion is affected by KLF2.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From Discussion KLF2-null mice die during embryogenesis due to a defective vasculature, 11 but the exact stage of endothelial differentiation that is critically affected by the absence of KLF2 remains to be identified.
We have recently shown that KLF2 is responsible for the shear-stress modulated expression of several genes involved in the regulation of vascular tone, including eNOS, which is one of the prime functions of the arterial endothelium. 10 In the current study, we describe the steady-state changes in endothelial gene expression after a prolonged stable overexpression of human KLF2 from the moderate PGK promoter, obtaining similar levels as achieved by prolonged flow exposure. The
Lenti-virus driven expression of KLF2 has several advantages over other expression systems, notably the ability of stable integration and overexpression for up to months, reaching near to 100% transduction efficiencies, without inducing substantial aspecific (inflammatory) side effects. The present study has identified a KLF2-induced gene expression profile that triggers an enhanced healthy and quiescent endothelial phenotype. The concerted regulation of multiple instead of single genes within various functional categories makes a strong observation and directly implies their potential physiological significance. Some recent studies have functionally substantiated our findings with regard to angiogenesis, inflammation, haemostasis and vascular tone. [7] [8] [9] [10] In the current study, the KLF2-mediated modulation of multiple genes that are involved in cell migration (Table 2) is shown to result in inhibition of wound healing (Fig. 3) , thereby suggesting a novel way in which KLF2 can inhibit the angiogenic response, in addition to recent in vivo findings. 9 Furthermore, an important role for KLF2 in modulating the expression of the basal levels of many anti-and proinflammatory genes is revealed (Table 2) , including MCP-1 and TM. In agreement with published data, 7 the response of the endothelium to inflammatory stimuli is repressed, as shown by the reduced efficacy of TNF-α to modulate the expression of TM and PAI-1 in KLF2-overexpressing HUVEC (Fig. 5) . Finally, we have now extended the subset of well-known flowresponsive genes that are involved in controlling vascular tone and owe their shear stress sensitivity to their direct transcriptional control by KLF2, as we have recently demonstrated by combining flow and KLF2-RNA interference. 10 The most notable exception to this set is prostacyclin synthase (PGIS), which is unchanged by KLF2 itself. The reported increased PGI2-bioavailability in response only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From to flow might very well be accomplished by the highly increased expression of the KLF2-induced prostaglandin transporter SLCO2A1, which itself was previously shown to be highly responsive to shear stress. 33 Collectively, the presented data lead to the novel insight that KLF2 gene regulation is almost entirely dedicated to the control of many of the genes that define the key functions of the normal functioning endothelium of the completely developed healthy arterial tree. The large number of downstream transcriptional targets of KLF2 (Table 2 ) precludes a simple direct transcription factor-to-function relation. For example, PAI-1 is not only critical in controlling haemostasis/fibrinolysis, but is also intricately involved in cell migration 34 and TM is involved in anti-coagulation but also contributes to embryonic development 35 and has anti-inflammatory properties. 36 The reduction of cell migration can therefore be related to a collection of genes, including a potential contribution of VEGFR2, which was reported to be responsible for reduced in vivo angiogenesis. 9 Phosphorylation of VEGFR2 residues Y951 and Y1059 is respectively associated with VEGF-induced cell migration and proliferation. 37 However, KLF2 did not significantly change the VEGF-induced phosphorylation at these sites (Fig. 3C) , making the involvement of the KLF2-mediated reduction in VEGFR2 expression in the inhibition of migration unlikely. In contrast to the lack of Y951 phosphorylation in pericyte-associated mature endothelial cells in vivo, 38 we did not observe Y951 silencing in our cell culture experiments, likely due to the absence of pericytes and shorter VEGF stimulation time intervals. Since angiogenesis is not affected in KLF2 null-mice and VEGFR2 -/-mice die at a much earlier time in development than KLF2 -/-mice, 11,39 VEGFR2 repression alone does not seem to offer a satisfactory explanation for the observed abrogation of endothelial cell migration. As shown in Table 2 many more genes involved in migration are affected by KLF2 including SEMA3F, a secreted member of the class 3 semaphorins. A recent report established the major inhibitory effect of SEMA3F on the migration of HUVEC on fibronectin in a similar migration assay as used in the only.
For 23 In addition, the expression of important basement membrane and/or vascular matrix proteins (fibulin-2, elastin and collagen type IV, α1) is significantly affected by KLF2 (Table 2) , providing the possibility that a change in composition of the endothelial matrix profoundly alters cell migration. Furthermore, observed changes in expression of matrix metalloproteinases and their inhibitors (TIMP3) could contribute as well. 40 The modestly higher vWF mRNA levels in the KLF2-overexpressing cultures (Fig. 1B) result in an increased average protein level of vWF per individual cell as a consequence of the increase in the number of cells that are filled with WPBs (Fig. 4E,F and 6A ). This pattern of expression is much more reminiscent of in vivo vascular endothelium, where consistent vWF expression is a hallmark of an intact endothelial cell monolayer. 6, 10, 41 Studies using vWF
demonstrated that the absence of vWF in regions of disturbed flow, largely prevents formation of atherosclerotic lesions at these predisposed sites. 42 In this respect, the absence of KLF2 at low-shear sites 10 might attenuate the storage of vWF in WPBs or lead to increased basal release of proatherogenic vWF at these sites. In contrast to epinephrine and forskolin, the secretion of vWF induced by physiological levels of thrombin is significantly attenuated by KLF2, providing an additional anti-thrombotic effect of KLF2 that is consistent with the role of vWF release at low shear stress regions of the vasculature in atherosclerosis. 42 The restriction of this effect to thrombin can be well explained by the considerable increase of functional surface TM levels observed in KLF2-overexpressing cells (Fig. 4A,B and 5 ). The high affinity of thrombin for TM thus results in effective competition between TM and the thrombin receptor, 43 the latter being essential for the thrombininduced but not epinephrine-induced WPB exocytosis. Both the lack of effect of the siRNAmediated knock-down of KLF2 on the WPBs in normal HUVEC (data not shown), as well as the published moderately suppressive effect of KLF2 on isolated vWF promoter constructs, 8 suggest that the change in cellular WPB distribution that is induced by KLF2 (Fig. 4E,F and 6 ) is likely due to only.
knock-out mouse phenotype where the absence of KLF2 in the endothelium of KLF2 -/-mice causes a poorly formed tunica media, resulting in blood vessel rupture. 11 As smooth muscle cells lack detectable KLF2, 6 this effect should also be attributed to endothelial paracrine factors. However, due to the unexpectedly high number of KLF2 responsive genes, which includes multiple endothelial marker genes and genes that encode for many secreted proteins, prostaglandin and proteoglycan molecules, the definition of an obvious molecular mechanism that accounts for the destabilization of the vessel wall in KLF2 -/-mice is precluded at present. 
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